[Comparative study of the clinical efficacy and safety of the fixed dose combination Levroso Long with Melaxen and Diphenhydramine in patients with drowsiness].

Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2023)

The study showed that Levroso Long in two dosages surpassed monotherapy with 50 mg of Diphenhydramine (50 mg) or Melaxen (3 mg) in patients with insomnia in terms of efficacy parameters. The benefit/risk ratio of the studied drug is favorable compared to monotherapy.

Keyphrases

combination therapy
open label
emergency department
clinical trial
randomized controlled trial
depressive symptoms
drug induced